journal article·2020-10

Modification of decellularized vascular xenografts with 8‐arm polyethylene glycol suppresses macrophage infiltration but maintains graft degradability

Atsushi Mahara, Marina Kitai, Hiroyasu Masunaga, Takaaki Hikima, Yuichi Ohya, Sono Sasaki, Shinichi Sakurai, Tetsuji Yamaoka

Publisher page

Abstract

Abstract Because acellular vascular xenografts induce an immunological reaction through macrophage infiltration, they are conventionally crosslinked with glutaraldehyde (GA). However, the GA crosslinking reaction inhibits not only the host immune reaction around the graft but also the graft's enzymatic degradability, which is one of the key characteristics of acellular grafts that allow them to be replaced by host tissue. In this study, we used an 8‐arm polyethylene glycol (PEG) to successfully suppress macrophage infiltration, without eliminating graft degradation. Decellularized ostrich carotid arteries were modified with GA or N‐hydroxysuccinimide‐activated 8‐arm PEG (8‐arm PEG‐NHS), which has a molecular weight of 17 kDa. To evaluate the enzymatic degradation in vitro, the graft was immersed in a collagenase solution for 12 hr. The 8‐arm PEG‐modified graft was degraded to the same extent as the unmodified graft, but the GA‐modified graft was not degraded. The graft was transplanted into rat subcutaneous tissue for up to 8 weeks. Although CD68‐positive cells accumulated in the unmodified graft, they did not infiltrate into either modified graft. However, the GA‐modified grafts calcified, but the 8‐arm PEG‐modified graft did not calcify after transplantation. These data suggested that 8‐arm PEG‐NHS is a promising modification agent for biodegradable vascular xenografts, to suppress acute macrophage infiltration only.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering National Cerebral and Cardiovascular Center Research Institute Kishibe Shin‐machi Suita Osaka Japan

Faculty of Chemistry, Materials and Bioengineering Kansai University 3‐3‐35 Yamatecho, Suita, Osaka Japan

Registered Institution for Facilities Use Promotion Japan Synchrotoron Radiation Research Institute (JASRI) Sayo‐gun Hyogo Japan

Department of Biobased Materials Science Kyoto Institute of Technology Kyoto Japan

Funding

Japan Agency for Medical Research and Development

References (50)

Show source-provided references
1. 10.1016/j.smim.2007.11.00410.1016/j.smim.2007.11.004 ↗
2. 10.1016/j.biomaterials.2010.09.00410.1016/j.biomaterials.2010.09.004 ↗
3. 10.1016/j.smim.2007.11.00310.1016/j.smim.2007.11.003 ↗
4. 10.1089/ten.tea.2007.026410.1089/ten.tea.2007.0264 ↗
5. 10.1016/S0002-9440(10)63048-910.1016/S0002-9440(10)63048-9 ↗
6. 10.2144/00011375410.2144/000113754 ↗
7. 10.1002/jbm.a.1042510.1002/jbm.a.10425 ↗
8. 10.1016/S0022-5223(19)42561-010.1016/S0022-5223(19)42561-0 ↗
9. 10.1016/0142-9612(96)85909-610.1016/0142-9612(96)85909-6 ↗
10. 10.1016/S0142-9612(97)00033-110.1016/S0142-9612(97)00033-1 ↗
11. 10.1016/j.jbiotec.2005.06.02910.1016/j.jbiotec.2005.06.029 ↗
12. 10.1016/S0002-9440(10)62227-410.1016/S0002-9440(10)62227-4 ↗
13. 10.1016/j.athoracsur.2011.04.10410.1016/j.athoracsur.2011.04.104 ↗
14. 10.1126/scitranslmed.300142610.1126/scitranslmed.3001426 ↗
15. 10.1016/j.biomaterials.2011.09.04010.1016/j.biomaterials.2011.09.040 ↗
16. 10.1016/j.coche.2013.12.00110.1016/j.coche.2013.12.001 ↗
17. 10.1021/ar900035f10.1021/ar900035f ↗
18. Size‐dependent permeability of hydrophilic probes across rabbit colonic epithelium
19. 10.1016/S0735-1097(00)00834-210.1016/S0735-1097(00)00834-2 ↗
20. 10.1038/nrd103310.1038/nrd1033 ↗
21. Hermanson G. T. · 1996
22. 10.1016/j.biomaterials.2004.04.03410.1016/j.biomaterials.2004.04.034 ↗
23. 10.1098/rsif.2008.033510.1098/rsif.2008.0335 ↗
24. 10.1089/biores.2012.028910.1089/biores.2012.0289 ↗
25. 10.1016/0142-9612(94)90036-110.1016/0142-9612(94)90036-1 ↗
26. 10.1517/1472821090290784710.1517/14728210902907847 ↗
27. 10.1016/j.biomaterials.2011.10.05410.1016/j.biomaterials.2011.10.054 ↗
28. 10.1021/la904111r10.1021/la904111r ↗
29. 10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P ↗
30. 10.1016/j.biomaterials.2003.09.10910.1016/j.biomaterials.2003.09.109 ↗
31. 10.1080/09205063.2014.93692610.1080/09205063.2014.936926 ↗
32. 10.1002/jbm.a.3601810.1002/jbm.a.36018 ↗
33. 10.1016/j.colsurfb.2019.06.03710.1016/j.colsurfb.2019.06.037 ↗
34. 10.1016/j.biomaterials.2015.04.03110.1016/j.biomaterials.2015.04.031 ↗
35. 10.1021/bm060250t10.1021/bm060250t ↗
36. 10.1093/rheumatology/ket27810.1093/rheumatology/ket278 ↗
37. 10.1021/bc700387810.1021/bc7003878 ↗
38. 10.1007/s10047-018-1042-510.1007/s10047-018-1042-5 ↗
39. 10.1007/s10047-019-01114-610.1007/s10047-019-01114-6 ↗
40. 10.1126/science.284.5413.48910.1126/science.284.5413.489 ↗
41. 10.1016/j.transproceed.2008.02.02510.1016/j.transproceed.2008.02.025 ↗
42. 10.1016/j.ejcts.2008.05.01210.1016/j.ejcts.2008.05.012 ↗
43. 10.1097/HJH.0b013e328356c25710.1097/HJH.0b013e328356c257 ↗
44. 10.1007/s10047-014-0768-y10.1007/s10047-014-0768-y ↗
45. 10.1002/jbm.a.3186310.1002/jbm.a.31863 ↗
46. Tissue‐engineered blood vessels in pediatric cardiac surgery
47. 10.1002/jbm.a.3306110.1002/jbm.a.33061 ↗
48. 10.1016/j.actbio.2015.01.02810.1016/j.actbio.2015.01.028 ↗
49. 10.1016/j.biomaterials.2018.06.02210.1016/j.biomaterials.2018.06.022 ↗
50. 10.1007/s10856-011-4326-310.1007/s10856-011-4326-3 ↗